Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.
about
Strategies for early detection of resectable pancreatic cancerMolecular detection of pancreatic neoplasia: Current status and future promiseThe role of suppressors of cytokine signalling in human neoplasmsIdentification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profilingWhole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot studyGenomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Precursor lesions of pancreatic cancer.Molecular signatures of pancreatic cancer.Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.STAT-3 correlates with lymph node metastasis and cell survival in gastric cancerEnforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice.Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.DNA methylation in haematological malignancies: the role of decitabine.PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.Signal transducers and activators of transcription: insights into the molecular basis of oral cancer.Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemiaExpression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.Identifying molecular markers for the early detection of pancreatic neoplasia.Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell linePancreatic cancer screeningDNA methylation: its role in cancer development and therapy.Epigenetics and epigenetic alterations in pancreatic cancer.Expression of SOCS-1 in the liver tissues of chronic hepatitis B and its clinical significance.Suppression of cytokine signaling: the SOCS perspective.Animal Models of Maternal Immune Activation in Depression Research.PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.Molecular pathogenesis of pancreatic cancer and clinical perspectives.Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis.Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells.SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence.Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma.Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation.SOCS1 gene promoter methylation status is associated with in-stent restenosis after percutaneous coronary intervention.
P2860
Q24564006-E771FBC4-D2E3-43B9-803D-646C99C1D6F2Q26777379-32868047-016D-4408-9356-C3E4E0BD151DQ27026783-8BD32EBC-6EAB-4263-AC53-F5D007B9244CQ28238147-4FB520A6-4D76-4961-94DD-206477483945Q28729757-1797F657-933F-4300-9652-20466BDB52A6Q33838679-EB43CBF0-9B33-4C0E-B4B2-F21B446FB5B6Q33855814-956E41DA-F1C0-4EFA-A407-8B5C0CE333C0Q33918801-05B49830-2941-4D75-BC71-69C37764BF14Q34196062-79A85BDA-6EA9-4A43-9165-C6D75800A7AEQ34306802-32C46BED-94D5-4609-9177-F9CF146C1072Q34543476-CAAD3C08-79E8-45BC-AB6D-7EA381B271E6Q35020444-168466F8-9B22-4F3A-994D-9BB8036E91E6Q35588740-A62A8B30-AB9C-4750-87F4-DA4D41F22AB9Q35594048-47972083-67BB-4F67-A907-4A6FDF2203B5Q35606891-D1B6BB9F-6F25-44CF-A7CA-774883B5DD00Q35911353-F63B1C41-C447-4429-B668-8F0D29AC30B7Q36238674-EF0A1D5C-B81C-4A9B-800F-4EF19EB75E87Q36290408-1A3DC344-D3CE-4988-B971-4B884A4B1B85Q36328508-A694B831-6105-4387-9973-E8AAEC5B60D6Q36695660-27FC8C90-1352-42B3-AB81-BA066172B101Q36896536-57148E51-82D6-44DA-B268-E65282A650B4Q36986433-34203E7B-EAD2-4AE5-B239-0568607C18AAQ37041763-EDBEA6FA-AD41-45E1-83EA-507C79B6D480Q37189619-32F1BB25-5E81-4FDC-B9A7-E1D65A2D90A4Q37278469-0F1B1EC1-86FE-49C7-AF3B-A292643F35C9Q37310541-5A326F8D-2520-4DC5-99FC-42F28BFD5CC6Q37558625-AC979354-5745-4007-B67B-341961B74A2FQ37960816-03CB7776-9CD1-4C41-8061-CF024C1DA892Q38319885-E03ED7EA-490B-4040-8F91-3915AD6A356FQ38853116-57FDBFE2-3E1B-434D-AF1A-2AA56FB27ED6Q38904799-EBAD55A3-0930-442D-83ED-1B8F092D1AC7Q39359156-37C3A297-5663-44E6-8030-5B886B1CDCA9Q39435653-453C62C7-C239-4858-B404-02EE65F4E88DQ39441167-A0C3281C-94ED-4438-BD8B-43B947B46333Q39858269-54029033-F6F7-4937-8FF2-2EC85E0BDD1BQ40155875-7CFBD055-71AB-464F-8A98-6FC6C42ABC02Q40477164-D04F49AE-7A99-4F6B-84A3-4851F06E049CQ40522793-3E500A1C-1DD8-46EB-A6B5-EA9B4FE1A863Q41112386-FD908C3C-00A9-4838-97B6-531DC60E91E7Q41343821-D42D7D68-CB30-41A0-AE33-35782AB8EF4A
P2860
Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Aberrant methylation of suppre ...... n pancreatic ductal neoplasms.
@ast
Aberrant methylation of suppre ...... n pancreatic ductal neoplasms.
@en
type
label
Aberrant methylation of suppre ...... n pancreatic ductal neoplasms.
@ast
Aberrant methylation of suppre ...... n pancreatic ductal neoplasms.
@en
prefLabel
Aberrant methylation of suppre ...... n pancreatic ductal neoplasms.
@ast
Aberrant methylation of suppre ...... n pancreatic ductal neoplasms.
@en
P2093
P2860
P356
P1476
Aberrant methylation of suppre ...... n pancreatic ductal neoplasms.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601039
P407
P577
2003-07-01T00:00:00Z